Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020

This cross-sectional study uses data from the US Food and Drug Administration (FDA) to review the postmarketing requirements and commitments attached to new vaccines approved for use in the past 15 years in the United States.

Detalles Bibliográficos
Autores principales: Moneer, Osman, Lee, ChangWon C., Avorn, Jerry, Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087952/
https://www.ncbi.nlm.nih.gov/pubmed/33929526
http://dx.doi.org/10.1001/jamanetworkopen.2021.8530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087952/
https://www.ncbi.nlm.nih.gov/pubmed/33929526
http://dx.doi.org/10.1001/jamanetworkopen.2021.8530

Ejemplares similares